When white blood cells, meant to protect the body from infection, are overly activated, they eject their DNA into nets, further disrupting the immune system and making patients more likely to develop a potentially severe reaction to immunotherapy.

Changing how often a popular cancer therapy is delivered would reduce greenhouse gas emissions and improve environmental impact without decreasing cancer survival, according to a new analysis from researchers at the University of Michigan Health Rogel Cancer Center.

Nearly 200 Medical School faculty members earned promotions in the 2024 cycle. Their new appointments were approved May 16 by the U-M Board of regents and take effect Sept. 1, 2024.

A melanoma survivor shares facts and tips about preventing all types of skin cancer.

Commencement ceremonies are, by design, full of Pomp and Circumstance. There are speeches to deliver and diplomas to dispense. And, of course, there is an air of celebration and accomplishment for the graduates and their families and friends. The 2024 Medical School M.D. graduation ceremony had all of this, as well as an added layer of humor when William Flanary, M.D., a prolific writer of both medicine and comedy, delivered the Commencement address May 10 in Hill Auditorium.

In the second season of The Fundamentals podcast, co-hosts Kelly Malcom and Jordan Goebig talk to several leading experts from the Medical School about their fields and the fundamental questions they are trying to answer — and discover why U-M is such an amazing place for research. Six new episodes of the popular podcast were released on May 6

The availability of clinical trials of new treatments for cancer varies greatly by geography, and a new study shows more socially vulnerable areas have far fewer.

An ophthalmologist and beloved comedian shares his thoughts on the field to aspiring clinicians.

Today on The Fundamentals is Dr. Maria Castro, the R.C. Schneider collegiate professor of neurosurgery, and a professor of cell and developmental biology at the University of Michigan Medical School. Her research program aims to develop immunotherapies for primary and metastatic brain cancer, studying basic immune biology mechanisms leading to clinical implementation. She has been inducted into the American Association for the Advancement of Sciences, the Latin American Academy of Sciences, and the American Institute for Medical and Biological Engineering College of Fellows. She has won numerous awards for her contributions to basic science and cancer research and is a diversity ambassador for the Cancer Biology Graduate Training Program. You can learn more about Dr. Castro here, and you can follow her @castro2355_mg, the Rogel Cancer Center @UMRogelCancer, the department of neurosurgery @umichneuro, Michigan Neurscience Institute @UM_MNI and the department of cell and developmental biology @UMCDB on X

When M4 Ahmad Hider crosses the stage at Hill Auditorium this week to receive his diploma and officially become Dr. Hider, like his fellow graduates he is excited about the future that awaits him in residency and beyond. As Hider becomes more fully immersed in the health care system, however, he also feels that many things need fixing. So, when he begins a residency in general surgery at University of Colorado Anschutz Medical Campus, he is preparing to for a dual role — becoming the best surgeon he can, and improving health care for patients.

A study led by University of Michigan Health Rogel Cancer Center researchers identifies novel biomarkers in renal cell carcinomas.

Experts in brain cancer outline current discoveries and offer a path of hope for glioblastoma treatment

Paul Picton, M.B., Ch.B., MRCP, FRCA, has been appointed interim chair of the Department of Anesthesiology in the Medical School, effective May 1. The provost has provided interim approval of his appointment, and it will be reported at the May Board of Regents meeting

Four with Medical School ties are among 12 University of Michigan faculty and staff members recognized by the American Association for the Advancement of Science (AAAS) as 2023 fellows in recognition of their extraordinary achievements.

A new urine-based test addresses a major problem in prostate cancer: how to separate the slow growing form of the disease unlikely to cause harm from more aggressive cancer that needs immediate treatment.